research about a company

User Generated

2fgrira

Writing

Description

what happened to the Theranos Company?

this is going to be a research paper about the Theranos company. And will go over the problem that they face on their laboratory.

this paper should be 6 pages and single space APA style

User generated content is uploaded by users for the purposes of learning and should be used following Studypool's honor code & terms of service.

Explanation & Answer

Here you go! Let me know in case you need any edits or clarifications.Thanks!

Running Head: THE RISE AND FALL OF THERANOS INC.

1

Contents
Title Page. ......................................................................................Error! Bookmark not defined.
The Rise and fall of Theranos Inc ..................................................Error! Bookmark not defined.
References ......................................................................................Error! Bookmark not defined.


Running Head: THE RISE AND FALL OF THERANOS INC.

The Rise and fall of Theranos Inc.
Student’s Name
Institution’s Name

Date

1

THE RISE AND FALL OF THERANOS INC.

2

The Rise and fall of Theranos Inc.
Theranos, Inc. was formed in 2003 and has its headquarters at Palo Alto, California. The
firm is operating clinical laboratories in Pennsylvania and Arizona, California. The firm is an
expert in geriatrics, pediatrics and oncology. Theranos is also known for manufacturing,
developing, designing and testing products within the U.S. operates clinical laboratories in
Arizona, California, and Pennsylvania.
Theranos, Inc. reported that it had achieved a worldwide settlement concurrence with the
Centers for Medicare and Medicaid Services (CMS) that resolves all extraordinary legitimate and
administrative procedures amongst CMS and Theranos. In accordance with the terms of the
settlement, CMS has pulled back the disavowal of the organization's CLIA working
endorsements and diminished its common fiscal punishment against the organization to $30,000.
As a component of the understanding, Theranos certified that predictable with the strategies for
success it sketched out the previous fall, the organization won't possess or work a clinical
research facility inside the following two years (Popken, 2017).
Blood-testing startup Theranos worked for a considerable length of time in close
aggregate mystery, in spite of raising a huge number of dollars at being estimated to be $9
billion. Truth be told, the vast majority did not know it existed but when Fortune interviewed
CEO and author Elizabeth Holmes in June 2014, the cover was blown.
Over the a couple of 16 months, Holmes became a star in Silicon Valley and even
featured in a number of magazines, including Fortune. Her custom was in tech business and led
her organization in performing numerous laboratory tests. It was during these tests that the firm
seemed to reform, almost changing how people view human services as described in the 2016
IPO. In the previous a little while, in any case, Theranos has encountered a quick go wrong with a genuine investigation (and some harming affirmations) originating from the media, the
legislature, and the organization's business accomplices (Bilton, 2016).
The Wall Street Journal put a monster stick in the Theranos expand, distributing a report
that blamed the organization for not really utilizing its own particular innovation to lead the
majority of its blood tests. In addition, The Journal reported that not more than 10% of the tests
provided by the company, Theranos, had any correlation to finger sticks. This implied that it, as a
rule, was a requirement to use standard venipuncture (i.e., syringe in the internal elbow and
substantially more than a couple drops of blood). In addition, the story addresses the validity of
Theranos lab results and the outcome results proposed that the organization had undermined
capability tests which are indispensable to keeping up laboratory affirmations.
Theranos instantly debated the charges by means of a blog entry, yet the counters were
more explanatory as opposed to being substantive. Fortune's Roger Parloff, responsible for
composing the main story, soon thereafter distributed a Q&A with Theranos giving the general
direction of Heather King. Once this was done, he presumed that there "were unmistakably
hopeless clashes between the organization's record and the Journal's." His inclusions made one
thing clear about Theranos; the firm was "dialing back" its advertising with the guarantee that
"one drop could change everything."
On the other hand,...


Anonymous
Just the thing I needed, saved me a lot of time.

Studypool
4.7
Trustpilot
4.5
Sitejabber
4.4

Related Tags